Nicola Lambri

Dr. Nicola Lambri

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2022 in Journal of Open Source Software
Verified
Journal Article
Open access
PDF file
SBSimon Biggs
Simon Biggs
MJMatthew Jennings
Matthew Jennings
SSStuart Swerdloff
Stuart Swerdloff
PCPhillip Chlap
Phillip Chlap
DLDerek Lane
Derek Lane
MSMatthew Sobolewski
Matthew Sobolewski

25 April 2023 in Physica Medica
Verified
Journal Article
Closed access
NLNicola Lambri
Nicola Lambri
VHVictor Hernandez
Victor Hernandez
JSJordi Sáez
Jordi Sáez
MPMarco Pelizzoli
Marco Pelizzoli
SPSara Parabicoli
Sara Parabicoli
PMPietro Mancosu
Pietro Mancosu

Verified
Journal Article
Open access
PDF file
CFCiro Franzese
Ciro Franzese
DDDamiano Dei
Damiano Dei
NLNicola Lambri
Nicola Lambri
MTMaria Ausilia Teriaca
Maria Ausilia Teriaca
MBMarco Badalamenti
Marco Badalamenti
MSMarta Scorsetti
Marta Scorsetti
Background: Head and neck cancer (HNC) is characterized by complex-shaped tumors and numerous organs at risk (OARs), inducing challenging radiotherapy (RT) planning, optimization, and delivery. In this review, we provided a thorough description of the applications of artificial intelligence (AI) tools in the HNC RT process. Methods: The PubMed database was queried, and a total of 168 articles (2016–2022) were screened by a group of experts in radiation oncology. The group selected 62 articles, which were subdivided into three categories, representing the whole RT workflow: (i) target and OAR contouring, (ii) planning, and (iii) delivery. Results: The majority of the selected studies focused on the OARs segmentation process. Overall, the performance of AI models was evaluated using standard metrics, while limited research was found on how the introduction of AI could impact clinical outcomes. Additionally, papers usually lacked information about the confidence level associated with the predictions made by the AI models. Conclusions: AI represents a promising tool to automate the RT workflow for the complex field of HNC treatment. To ensure that the development of AI technologies in RT is effectively aligned with clinical needs, we suggest conducting future studies within interdisciplinary groups, including clinicians and computer scientists.

8 August 2022 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
PMPietro Mancosu
Pietro Mancosu
NLNicola Lambri
Nicola Lambri
ICIsabella Castiglioni
Isabella Castiglioni
DDDamiano Dei
Damiano Dei
MIMauro Iori
Mauro Iori
MAMichele Avanzo
Michele Avanzo
This topical review focuses on the applications of artificial intelligence (AI) tools to stereotactic body radiation therapy (SBRT). The high dose per fraction and the limited number of fractions in SBRT require stricter accuracy than standard radiation therapy. The intent of this review is to describe the development and evaluate the possible benefit of AI tools integration into the radiation oncology workflow for SBRT automation. The selected papers were subdivided into four sections, representative of the whole radiotherapy process: ‘AI in SBRT target and organs at risk contouring’, ‘AI in SBRT planning’, ‘AI during the SBRT delivery’, and ‘AI for outcome prediction after SBRT’. Each section summarises the challenges, as well as limits and needs for improvement to achieve better integration of AI tools in the clinical workflow.

28 February 2023 in Cancers
Verified
Journal Article
Open access
PDF file
DDDamiano Dei
Damiano Dei
NLNicola Lambri
Nicola Lambri
SSSara Stefanini
Sara Stefanini
VVVeronica Vernier
Veronica Vernier
RBRicardo Coimbra Brioso
Ricardo Coimbra Brioso
PMPietro Mancosu
Pietro Mancosu
Background: The total marrow and lymph node irradiation (TMLI) target includes the bones, spleen, and lymph node chains, with the latter being the most challenging structures to contour. We evaluated the impact of introducing internal contour guidelines to reduce the inter- and intraobserver lymph node delineation variability in TMLI treatments. Methods: A total of 10 patients were randomly selected from our database of 104 TMLI patients so as to evaluate the guidelines’ efficacy. The lymph node clinical target volume (CTV_LN) was recontoured according to the guidelines (CTV_LN_GL_RO1) and compared to the historical guidelines (CTV_LN_Old). Both topological (i.e., Dice similarity coefficient (DSC)) and dosimetric (i.e., V95 (the volume receiving 95% of the prescription dose) metrics were calculated for all paired contours. Results: The mean DSCs were 0.82 ± 0.09, 0.97 ± 0.01, and 0.98 ± 0.02, respectively, for CTV_LN_Old vs. CTV_LN_GL_RO1, and between the inter- and intraobserver contours following the guidelines. Correspondingly, the mean CTV_LN-V95 dose differences were 4.8 ± 4.7%, 0.03 ± 0.5%, and 0.1 ± 0.1%. Conclusions: The guidelines reduced the CTV_LN contour variability. The high target coverage agreement revealed that historical CTV-to-planning-target-volume margins were safe, even if a relatively low DSC was observed.

22 July 2023 in Current Oncology
Verified
Journal Article
Open access
PDF file
STStefano Tomatis
Stefano Tomatis
PMPietro Mancosu
Pietro Mancosu
GRGiacomo Reggiori
Giacomo Reggiori
FLFrancesca Lobefalo
Francesca Lobefalo
PGPasqualina Gallo
Pasqualina Gallo
MSMarta Scorsetti
Marta Scorsetti
Background: Hypo-fractionation can be an effective strategy to lower costs and save time, increasing patient access to advanced radiation therapy. To demonstrate this potential in practice within the context of temporal evolution, a twenty-year analysis of a representative radiation therapy facility from 2003 to 2022 was conducted. This analysis utilized comprehensive data to quantitatively evaluate the connections between advanced clinical protocols and technological improvements. The findings provide valuable insights to the management team, helping them ensure the delivery of high-quality treatments in a sustainable manner. Methods: Several parameters related to treatment technique, patient positioning, dose prescription, fractionation, equipment technology content, machine workload and throughput, therapy times and patients access counts were extracted from departmental database and analyzed on a yearly basis by means of linear regression. Results: Patients increased by 121 ± 6 new per year (NPY). Since 2010, the incidence of hypo-fractionation protocols grew thanks to increasing Linac technology. In seven years, both the average number of fractions and daily machine workload decreased by −0.84 ± 0.12 fractions/year and −1.61 ± 0.35 patients/year, respectively. The implementation of advanced dose delivery techniques, image guidance and high dose rate beams for high fraction doses, currently systematically used, has increased the complexity and reduced daily treatment throughput since 2010 from 40 to 32 patients per 8 h work shift (WS8). Thanks to hypo-fractionation, such an efficiency drop did not affect NPY, estimating 693 ± 28 NPY/WS8, regardless of the evaluation time. Each newly installed machine was shown to add 540 NPY, while absorbing 0.78 ± 0.04 WS8. The COVID-19 pandemic brought an overall reduction of 3.7% of patients and a reduction of 0.8 fractions/patient, to mitigate patient crowding in the department. Conclusions: The evolution of therapy protocols towards hypo-fractionation was supported by the use of proper technology. The characteristics of this process were quantified considering time progression and organizational aspects. This strategy optimized resources while enabling broader access to advanced radiation therapy. To truly value the benefit of hypo-fractionation, a reimbursement policy should focus on the patient rather than individual treatment fractionation.